These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 6801749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A, Chłopocka-Woźniak M, Rybakowski J.
    Psychiatr Pol; 2002 Sep; 36(6 Suppl):63-9. PubMed ID: 12647423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prediction of lithium response in affective disorders.
    Ananth J, Pecknold JC.
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lithium treatment of bipolar affective disorders under naturalistic followup conditions.
    Goldberg JF, Harrow M, Leon AC.
    Psychopharmacol Bull; 1996 Feb; 32(1):47-54. PubMed ID: 8927674
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E, García-López A, Nieves P, Rodríguez-Salvanés F.
    Actas Esp Psiquiatr; 2000 Feb; 28(3):156-60. PubMed ID: 11000697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG, Peselow E, Mulcare L, Case BG, Fieve R.
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Bipolar disorder. Follow-up of lithium therapy in a clinic].
    Agulló Hernández MD, Sanz Osorio MT, Barbarà Berdaguer M, Vallès i Callol V, Garolera Freixa M, Delgado Cruz L, Alberni i Coderch J.
    Rev Enferm; 2000 Mar; 23(3):177-80. PubMed ID: 10797777
    [Abstract] [Full Text] [Related]

  • 17. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A, Malitas PN, Mandelli L, Lorenzi C, Ploia C, Alevizos B, Nikolaou C, Boufidou F, Christodoulou GN, Smeraldi E.
    Pharmacogenomics J; 2004 Feb; 4(4):267-73. PubMed ID: 15111989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.